Advisory Committee to the Director (ACD), Centers for Disease Control (CDC) and Prevention-Ethics Subcommittee (ES), 58302 [E9-27269]
Download as PDF
<![CDATA[
58302
Federal Register / Vol. 74, No. 217 / Thursday, November 12, 2009 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 5, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–27269 Filed 11–9–09; 4:15 pm]
Dated: November 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–27198 Filed 11–10–09; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control
(CDC) and Prevention—Ethics
Subcommittee (ES)
jlentini on DSKJ8SOYB1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 3 p.m.–4 p.m., November
23, 2009.
Place: Teleconference. To participate,
please dial (866) 919–3560 and enter
passcode 4168828 for access.
Status: Open to the public; teleconference
access limited only by availability of
telephone ports. The public is welcome to
participate during the public comment
period, which is tentatively scheduled from
3:30 p.m. to 3:45 p.m.
Purpose: The Ethics Subcommittee will
provide counsel to the ACD, CDC, regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists and practitioners.
Matter to be Discussed: Ethical guidance
for ventilator distribution during a severe
pandemic. This notice is being published less
than 15 days prior to the meeting due to the
public health emergency declared on April
26, 2009. There is a critical need for this
subcommittee to deliberate and discuss
urgent matters related to the H1N1 virus and
be actively engaged in the national
preparedness and response efforts as dictated
by circumstances and events.
The agenda is subject to change as
priorities dictate.
Contact Person For More Information: Drue
Barrett, Ph.D., Designated Federal Officer,
ACD, CDC—ES, 1600 Clifton Road, NE., M/
S D–50, Atlanta, Georgia 30333. Telephone:
(404) 639–4690. E-mail: dbarrett@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Nov<24>2008
16:12 Nov 10, 2009
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Division of Intramural Research Board
of Scientific Counselors, NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: December 7–9, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Bethesda, MD
20892.
Contact Person: Kathryn C. Zoon, PhD,
Director, Division of Intramural Research,
National Institute of Allergy and Infectious
Diseases, NIH, Building 31, Room 4A30,
Bethesda, MD 20892, 301–496–3006,
kzoon@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–27195 Filed 11–10–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Form I–134; Extension of an
Existing Information Collection;
Comment Request
ACTION: 60-Day Notice of Information
Collection Under Review; Form I–134,
Affidavit of Support; OMB Control No.
1615–0014.
The Department Homeland Security,
U.S. Citizenship and Immigration
Services (USCIS) has submitted the
following information collection request
for review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted for
sixty days until January 11, 2010.
During this 60 day period, USCIS will
be evaluating whether to revise the
Form I–134. Should USCIS decide to
revise Form I–134 we will advise the
public when we publish the 30-day
notice in the Federal Register in
accordance with the Paperwork
Reduction Act. The public will then
have 30 days to comment on any
revisions to the Form I–134.
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burden and associated
response time, should be directed to the
Department of Homeland Security
(DHS), USCIS, Chief, Regulatory
Products Division, Clearance Officer,
111 Massachusetts Avenue, NW.,
Washington, DC 20529–2210.
Comments may also be submitted to
DHS via facsimile to 202–272–8352 or
via e-mail at rfs.regs@dhs.gov. When
submitting comments by e-mail, please
make sure to add OMB Control No.
1615–0014 in the subject box. Written
comments and suggestions from the
public and affected agencies concerning
the collection of information should
address one or more of the following
four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 74, Number 217 (Thursday, November 12, 2009)]
[Notices]
[Page 58302]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-27269]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control (CDC) and Prevention--Ethics Subcommittee (ES)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 3 p.m.-4 p.m., November 23, 2009.
Place: Teleconference. To participate, please dial (866) 919-
3560 and enter passcode 4168828 for access.
Status: Open to the public; teleconference access limited only
by availability of telephone ports. The public is welcome to
participate during the public comment period, which is tentatively
scheduled from 3:30 p.m. to 3:45 p.m.
Purpose: The Ethics Subcommittee will provide counsel to the
ACD, CDC, regarding a broad range of public health ethics questions
and issues arising from programs, scientists and practitioners.
Matter to be Discussed: Ethical guidance for ventilator
distribution during a severe pandemic. This notice is being
published less than 15 days prior to the meeting due to the public
health emergency declared on April 26, 2009. There is a critical
need for this subcommittee to deliberate and discuss urgent matters
related to the H1N1 virus and be actively engaged in the national
preparedness and response efforts as dictated by circumstances and
events.
The agenda is subject to change as priorities dictate.
Contact Person For More Information: Drue Barrett, Ph.D.,
Designated Federal Officer, ACD, CDC--ES, 1600 Clifton Road, NE., M/
S D-50, Atlanta, Georgia 30333. Telephone: (404) 639-4690. E-mail:
dbarrett@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: November 5, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-27269 Filed 11-9-09; 4:15 pm]
BILLING CODE 4163-18-P
